The therapeutic effect of the brd4-degrading protac a1874 in human colon cancer cells

HIGHLIGHTS

  • who: An-cheng Qin from the The primary human colon cancer cells from four written-informed consent primary colon cancer patients, pCan1/2/3/4, and primary human colon epithelial cells from two healthy donors, pEpi1/2, were provided by DrLu at Nanjing Medical University15-17. The primary human cells were cultured in the described medium15, . The established , colon cancer cells were also provided by Dr. Lu15-17. All the established and primary cells were subjected to routine mycoplasma and microbial contamination examination every, months. To confirm the genotype of the cells, STR (short tandem repeat) profiling . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?